Cathepsin G binding to human platelets. Evidence for a specific receptor

Area of Science:

• Biochemistry
• Hematology
• Cell Biology

Background:

• Human neutrophil cathepsin G is a known potent platelet agonist.
• Understanding the mechanism of cathepsin G-induced platelet activation is crucial for comprehending platelet function and related disorders.

Purpose of the Study:

• To investigate the binding characteristics of cathepsin G to human platelets.
• To elucidate the relationship between cathepsin G binding and platelet activation.
• To identify potential regulatory mechanisms of cathepsin G-platelet interaction.

Main Methods:

• Characterization of cathepsin G binding kinetics to human platelets using varying enzyme concentrations and temperatures.
• Assessment of platelet activation markers, including Ca2+ mobilization.
• Investigation of the effect of protein kinase activators (forskolin, PMA) on cathepsin G binding.

Main Results:

• Cathepsin G exhibits saturable, reversible binding to human platelets, indicative of a specific receptor.
• Binding demonstrates apparent positive co-operativity at room temperature, suggesting conformational changes or site exposure.
• Platelet activation occurs at cathepsin G concentrations lower than those required for maximal binding.
• Forskolin and PMA treatment decrease cathepsin G binding, suggesting receptor desensitization via phosphorylation.

Conclusions:

• Cathepsin G acts as an agonist that requires binding to a specific platelet receptor to initiate platelet activation.
• The binding affinity and co-operativity are influenced by temperature and enzyme activity.
• Platelet activation by cathepsin G involves occupancy of a fraction of available binding sites.
• Receptor availability may be regulated by phosphorylation-dependent mechanisms, highlighting potential negative feedback pathways.